News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
302,033 Results
Type
Article (16424)
Company Profile (300)
Press Release (285302)
Multimedia
Podcasts (89)
Webinars (11)
Section
Business (85089)
Career Advice (331)
Deals (14749)
Drug Delivery (47)
Drug Development (54056)
Employer Resources (35)
FDA (6590)
Job Trends (5887)
News (155949)
Policy (11092)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (986)
Accelerated approval (20)
Adcomms (16)
Allergies (82)
Alliances (23010)
ALS (125)
Alzheimer's disease (1056)
Antibody-drug conjugate (ADC) (268)
Approvals (6810)
Artificial intelligence (270)
Autoimmune disease (120)
Automation (9)
Bankruptcy (115)
Best Places to Work (5230)
BIOSECURE Act (7)
Biosimilars (107)
Biotechnology (231)
Bladder cancer (120)
Brain cancer (49)
Breast cancer (432)
Cancer (3523)
Cardiovascular disease (253)
Career advice (286)
Career pathing (10)
CAR-T (229)
CDC (6)
Cell therapy (588)
Cervical cancer (20)
Clinical research (46827)
Collaboration (1199)
Company closure (3)
Compensation (601)
Complete response letters (39)
COVID-19 (1195)
CRISPR (88)
C-suite (562)
Cystic fibrosis (114)
Data (4589)
Denatured (15)
Depression (94)
Diabetes (282)
Diagnostics (1615)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (10)
Drug discovery (196)
Drug pricing (54)
Drug shortages (5)
Duchenne muscular dystrophy (217)
Earnings (34711)
Editorial (26)
Employer branding (5)
Employer resources (32)
Events (53634)
Executive appointments (630)
FDA (8490)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1002)
Gene editing (185)
Generative AI (21)
Gene therapy (501)
GLP-1 (548)
Government (1307)
Grass and pollen (3)
Guidances (208)
Healthcare (7270)
HIV (22)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (200)
Immuno-oncology (45)
Indications (73)
Infectious disease (1314)
Inflammatory bowel disease (156)
Inflation Reduction Act (10)
Influenza (41)
Intellectual property (168)
Interviews (48)
IPO (7960)
IRA (14)
Job creations (953)
Job search strategy (242)
JPM (43)
Kidney cancer (11)
Labor market (26)
Layoffs (262)
Leadership (12)
Legal (1619)
Liver cancer (53)
Longevity (11)
Lung cancer (473)
Lymphoma (286)
Machine learning (24)
Management (7)
Manufacturing (398)
MASH (135)
Medical device (3372)
Medtech (3391)
Mergers & acquisitions (7448)
Metabolic disorders (796)
Multiple sclerosis (108)
NASH (14)
Neurodegenerative disease (238)
Neuropsychiatric disorders (73)
Neuroscience (1996)
Neurotech (1)
NextGen: Class of 2026 (2306)
Non-profit (987)
Now hiring (31)
Obesity (362)
Opinion (146)
Ovarian cancer (137)
Pain (105)
Pancreatic cancer (167)
Parkinson's disease (232)
Partnered (14)
Patents (311)
Patient recruitment (334)
Peanut (43)
People (27431)
Pharmaceutical (45)
Pharmacy benefit managers (6)
Phase 1 (15894)
Phase 2 (21367)
Phase 3 (14589)
Pipeline (3470)
Policy (100)
Postmarket research (1047)
Preclinical (6628)
Press Release (31)
Prostate cancer (173)
Psychedelics (51)
Radiopharmaceuticals (249)
Rare diseases (666)
Real estate (1594)
Recruiting (14)
Regulatory (10731)
Reports (20)
Research institute (1034)
Resumes & cover letters (46)
Rett syndrome (24)
RNA editing (21)
RSV (23)
Schizophrenia (124)
Series A (186)
Series B (137)
Service/supplier (1)
Sickle cell disease (78)
Special edition (18)
Spinal muscular atrophy (121)
Sponsored (18)
Startups (2045)
State (1)
Stomach cancer (13)
Supply chain (34)
Tariffs (24)
The Weekly (73)
Vaccines (382)
Venture capital (70)
Weight loss (203)
Women's health (31)
Worklife (5)
Date
Today (59)
Last 7 days (335)
Last 30 days (1224)
Last 365 days (18827)
2026 (1783)
2025 (19082)
2024 (21562)
2023 (23476)
2022 (28099)
2021 (29198)
2020 (24929)
2019 (17943)
2018 (13126)
2017 (14699)
2016 (12812)
2015 (15462)
2014 (11224)
2013 (8132)
2012 (8288)
2011 (8442)
2010 (8112)
Location
Africa (181)
Alabama (65)
Alaska (2)
Arizona (75)
Arkansas (6)
Asia (19134)
Australia (3403)
California (7312)
Canada (1935)
China (818)
Colorado (266)
Connecticut (267)
Delaware (255)
Europe (42056)
Florida (939)
Georgia (218)
Hawaii (2)
Idaho (19)
Illinois (422)
India (36)
Indiana (186)
Iowa (8)
Japan (251)
Kansas (84)
Kentucky (13)
Louisiana (8)
Maine (13)
Maryland (775)
Massachusetts (5699)
Michigan (112)
Minnesota (262)
Mississippi (3)
Missouri (35)
Montana (21)
Nebraska (6)
Nevada (38)
New Hampshire (25)
New Jersey (1856)
New Mexico (13)
New York (1833)
North Carolina (873)
North Dakota (6)
Northern California (3604)
Ohio (183)
Oklahoma (11)
Oregon (24)
Pennsylvania (1321)
Puerto Rico (9)
Rhode Island (25)
South America (254)
South Carolina (10)
Southern California (2878)
Tennessee (50)
Texas (957)
United States (24400)
Utah (108)
Virginia (141)
Washington D.C. (40)
Washington State (606)
West Virginia (2)
Wisconsin (60)
302,033 Results for "plus therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
·
5 min read
Press Releases
Plus Therapeutics Provides Business Update on REYOBIQ™ Clinical Program and U.S. CNSide® Commercialization
January 22, 2026
·
6 min read
Press Releases
Plus Therapeutics Expands CNSide Assay Platform to State of California
December 11, 2025
·
5 min read
Press Releases
Plus Therapeutics Announces Expansion of CNSide Team and Issuance of Inducement Grants
December 10, 2025
·
7 min read
Press Releases
Plus Therapeutics Updates on CNSide® Diagnostic Platform Launch
October 21, 2025
·
9 min read
Press Releases
Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, January 22, 2026 at 9:00 A.M. ET
January 22, 2026
·
3 min read
Press Releases
Plus Therapeutics Announces Read Out of Type B Meeting with the FDA with Goal of Accelerating Approval of REYOBIQ™ for Leptomeningeal Metastases
January 8, 2026
·
7 min read
Press Releases
Zomedica Launches Next-Generation VETGuardian PLUS(TM) Monitor, Expanding Core Monitoring Platform in Growing Veterinary Market
December 30, 2025
·
9 min read
Press Releases
Plus Therapeutics Reports Third Quarter Financial Results and Recent Business Highlights
October 31, 2025
·
13 min read
Press Releases
Plus Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
November 18, 2025
·
4 min read
1 of 30,204
Next
